Anti-IgE (omalizumab): a new therapeutic approach for chronic rhinosinusitis.

Sorry, there's nothing here.

Cite this paper

@article{Grundmann2008AntiIgEA, title={Anti-IgE (omalizumab): a new therapeutic approach for chronic rhinosinusitis.}, author={Sonja Alexandra Grundmann and Pia B Hemfort and Thomas Luger and Randolf Brehler}, journal={The Journal of allergy and clinical immunology}, year={2008}, volume={121 1}, pages={257-8} }